Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07475117 · ClinicalTrials.gov registry record · NA
Health Engagement & Access Through Learning, Training, and Health-coaching With People With Intellectual and/or Developmental Disabilities
A NA study, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- NA
- Development phase
- 1,040
- Enrollment target
NCT07475117: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.
NCT07475117 is a NA study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 1,040 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07475117, a NA study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,040 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a combination of an educational curriculum and health coaching embedded within Special Olympics improves health outcomes and healthcare access compared to regular Special Olympics sport and health programming for adults with intellectual and/or developmental disabilities.
Primary Outcome
GAS is measured using three participant-identified goals, each assigned a priority weight from 1 to 3 (3=most important goal to participant). At each assessment, each goal is assigned a score from -2 to +2, with 0 representing expected level of attainment and 2 indicating much more than expected level of attainment; goals are assigned a score of -2 at baseline. GAS score levels across all three participant goals are converted into a standardized single GAS T-score for each participant. The range
Interventions
- BEHAVIORAL Comprehensive Community Health
- OTHER Regular Special Olympics programming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,040 participants |
| Start Date | 2026-07 |
| Est. Completion | 2031-03 |
| Phase | NA |
What is known before NCT07475117 opens enrollment
NCT07475117 is an interventional study that assigns participants to a tested intervention. Its 1,040 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower).
The record links to 0 conditions, and to 2 interventions - of which Comprehensive Community Health is the first listed.
NCT07475117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07475117 about?
NCT07475117 is a clinical study titled "Health Engagement & Access Through Learning, Training, and Health-coaching With People With Intellectual and/or Developmental Disabilities". The purpose of this study is to see if a combination of an educational curriculum and health coaching embedded within Special Olympics improves health outcomes and healthcare access compared to regular Special Olympics sport and health programming for adults with intellectual and/or developmental di...
What is the current status of trial NCT07475117?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,040 participants. The study started on 2026-07. Estimated completion is 2031-03.
What interventions are being tested in trial NCT07475117?
The interventions under investigation include: Comprehensive Community Health (BEHAVIORAL), Regular Special Olympics programming (OTHER).
Who is sponsoring clinical trial NCT07475117?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07475117's enrollment target sits among peer trials
1,040 100th of 2000 higher than 1,900 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05219110 · 1,040 participants · NA
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- NCT06564948 · 1,040 participants · NA
Treatment for Individuals Interacting with the Criminal Justice System
- NCT06661720 · 1,040 participants · Phase 3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- NCT04685616 · 1,042 participants · Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia